Tandem Diabetes Care, Inc. (TNDM)
20.98
-0.48
(-2.21%)
USD |
NASDAQ |
Dec 11, 16:00
20.98
0.00 (0.00%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Investing (Quarterly): 20.54M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Insulet Corp. | -31.00M |
| Abbott Laboratories | -457.00M |
| Integra LifeSciences Holdings Corp. | -15.59M |
| Teleflex, Inc. | -767.50M |
| Perspective Therapeutics, Inc. | 13.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 8.264M |
| Cash from Financing (Quarterly) | -1.57M |
| Free Cash Flow | -25.12M |
| Free Cash Flow Per Share (Quarterly) | 0.0617 |
| Free Cash Flow to Equity (Quarterly) | 3.896M |
| Free Cash Flow to Firm (Quarterly) | 5.910M |
| Free Cash Flow Yield | -1.79% |